Werner Nicolas, Kilkowski C, Zahn R
Klinikum Ludwigshafen, Medizinische Klinik B, Bremserstr. 79, 67063, Ludwigshafen, Deutschland,
Herz. 2015 Aug;40(5):771-7. doi: 10.1007/s00059-015-4329-9.
Paravalvular leak (PVL) is a relatively rare, but serious complication occurring in up to 10% of patients after prosthetic aortic valve replacement and in up to 17% of patients after prosthetic mitral valve replacement. Up to 5% of patients will present with symptoms of congestive heart failure or mechanical haemolytic anaemia due to PVL and need further surgical or interventional treatment. Surgical repair is often technically challenging and carries a high mortality and morbidity risk. Catheter-based closure of PVL has emerged as an alternative approach especially for patients with relevant comorbidities at high surgical risk. Interventional closure of PVL is a complex procedure, which needs to be performed by an experienced team of interventional cardiologist, echocardiographer and anesthesiologist. To date available clinical results are promising showing low complication rates and high technical or clinical success rates of catheter-based closure of PVL (60-90%). Compared to surgical closure of PVL lower mortality rates (30-days mortality rate: 4,6%) have been documented in patients treated by catheter-based closure of PVL in clinical practice. Therefore interventional closure seems to be a promising option, which need to be discussed with every symptomatic patient suffering from PVL prior to therapeutical decision making. To date only sparse clinical data is available regarding indication and clinical outcome of patients undergoing catheter-based PVL in clinical practice. Therefore interventional closure of PVL should be limited to experienced interventional cardiologist at present. All patients treated should further be enrolled into a clinical registry to evaluate the safety and efficacy of catheter-based closure of PVL in clinical practice.
瓣周漏(PVL)是一种相对罕见但严重的并发症,在人工主动脉瓣置换术后高达10%的患者以及人工二尖瓣置换术后高达17%的患者中出现。高达5%的患者会因瓣周漏出现充血性心力衰竭或机械性溶血性贫血症状,需要进一步的手术或介入治疗。手术修复在技术上往往具有挑战性,且存在较高的死亡率和发病率风险。基于导管的瓣周漏封堵术已成为一种替代方法,尤其适用于具有相关合并症且手术风险高的患者。瓣周漏的介入封堵是一个复杂的过程,需要由经验丰富的介入心脏病专家、超声心动图专家和麻醉师团队来进行。迄今为止,可用的临床结果很有前景,显示基于导管的瓣周漏封堵术的并发症发生率低,技术或临床成功率高(60 - 90%)。与瓣周漏的手术封堵相比,在临床实践中接受基于导管的瓣周漏封堵术治疗的患者记录到较低的死亡率(30天死亡率:4.6%)。因此,介入封堵似乎是一个有前景的选择,在治疗决策前需要与每一位有症状的瓣周漏患者进行讨论。迄今为止,关于临床实践中接受基于导管的瓣周漏封堵术患者的适应症和临床结果仅有稀少的临床数据。因此,目前瓣周漏的介入封堵应限于经验丰富的介入心脏病专家。所有接受治疗的患者都应进一步纳入临床注册研究,以评估基于导管的瓣周漏封堵术在临床实践中的安全性和有效性。